BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33288364)

  • 1. Case for diagnosis. Erythematous and infiltrated plaques in the infrahyoid region.
    Bezerra NTC; Schettini APM; Leturiondo AL; Mathias LHMT
    An Bras Dermatol; 2021; 96(1):97-99. PubMed ID: 33288364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case for diagnosis. Infiltrated areas on the trunk.
    Góes LDM; Scrignoli JA; Morais P; Talhari C
    An Bras Dermatol; 2020; 95(5):652-654. PubMed ID: 32651045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems of multidrug therapy.
    Ramu G
    Indian J Lepr; 1991; 63(3-4):435-45. PubMed ID: 1804896
    [No Abstract]   [Full Text] [Related]  

  • 4. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leprosy in HIV infection: a study of three cases.
    Rath N; Kar HK
    Indian J Lepr; 2003; 75(4):355-9. PubMed ID: 15242274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genital involvement and type I reaction in childhood leprosy.
    Gupta R; Singal A; Pandhi D
    Lepr Rev; 2005 Sep; 76(3):253-7. PubMed ID: 16248212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
    Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
    Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
    Thomas A; Hari L; Nagarajan M; Prabhakar R
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facial tuberculoid leprosy: case report.
    Ali K; Sittampalam G; Malik MA
    Br J Oral Maxillofac Surg; 2011 Jan; 49(1):70-2. PubMed ID: 20188445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary leprosy infection in a patient with psoriasis during treatment with infliximab.
    Teixeira FM; Vasconcelos LM; Rola Cde A; Prata de Almeida TL; Valença JT; Nagao-Dias AT
    J Clin Rheumatol; 2011 Aug; 17(5):269-71. PubMed ID: 21778902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects of leprosy.
    Talhari C; Talhari S; Penna GO
    Clin Dermatol; 2015; 33(1):26-37. PubMed ID: 25432808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
    Kumar A; Girdhar A; Girdhar BK
    Acta Leprol; 2003; 12(3):123-8. PubMed ID: 15040703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges related to the cases of lepromatous leprosy: a report of two cases.
    Alfaragi M; Ahmed F; Osman W; Mustafa I; Almustafi I; Dawoud R; Alrashdi F
    Pan Afr Med J; 2022; 41():35. PubMed ID: 35382042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):292-303. PubMed ID: 2071986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leprosy. Pathogenesis--classification--diagnosis--treatment].
    Stingl P
    Hautarzt; 1990 Mar; 41(3):126-30. PubMed ID: 2188935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic observations on the persistence of Mycobacterium leprae in the skin of multibacillary leprosy patients under chemotherapy.
    Wabitsch KR; Meyers WM
    Lepr Rev; 1988 Dec; 59(4):341-6. PubMed ID: 2468983
    [No Abstract]   [Full Text] [Related]  

  • 20. A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients.
    Shetty VP; Wakade A; Antia NH
    Lepr Rev; 2001 Sep; 72(3):337-44. PubMed ID: 11715280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.